Amgen thyroid drug succeeds in late-stage trial

(Reuters) - Drugmaker Amgen Inc said its experimental drug to reduce thyroid levels in patients with chronic kidney disease met the main goal in a late-stage trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news